R01 CA128486-03/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2011	2
2012	1
2025	0

Page 1

Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo.

Biswas S, Dodwadkar NS, Deshpande PP, Torchilin VP. Biswas S, et al. J Control Release. 2012 May 10;159(3):393-402. doi: 10.1016/j.jconrel.2012.01.009. Epub 2012 Jan 20. J Control Release. 2012. PMID: 22286008 Free PMC article.

Screening and optimization of ligand conjugates for lysosomal targeting.

Meerovich I, Koshkaryev A, Thekkedath R, Torchilin VP. Meerovich I, et al. Bioconjug Chem. 2011 Nov 16;22(11):2271-82. doi: 10.1021/bc200336j. Epub 2011 Oct 6. Bioconjug Chem. 2011. PMID: 21913714 Free PMC article.

Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.

Biswas S, Dodwadkar NS, Sawant RR, Torchilin VP. Biswas S, et al. Bioconjug Chem. 2011 Oct 19;22(10):2005-13. doi: 10.1021/bc2002133. Epub 2011 Sep 12. Bioconjug Chem. 2011. PMID: 21870873 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year